142 related articles for article (PubMed ID: 30692362)
1. [A Case of Advanced Esophageal Cancer Successfully Treated with Neoadjuvant Chemotherapy Containing 5-FU, Docetaxel. and Nedaplatin Combination Therapy].
Kimura Y; Shiraishi O; Kawakami H; Ueda H; Okuno T; Hiraki Y; Kato H; Iwama M; Yasuda A; Shinkai M; Chikugo T; Imano M; Imamoto H; Nakagawa K; Yasuda T
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1812-1814. PubMed ID: 30692362
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study.
Ohnuma H; Sato Y; Hayasaka N; Matsuno T; Fujita C; Sato M; Osuga T; Hirakawa M; Miyanishi K; Sagawa T; Fujikawa K; Ohi M; Okagawa Y; Tsuji Y; Hirayama M; Ito T; Nobuoka T; Takemasa I; Kobune M; Kato J
Cancer Sci; 2018 Nov; 109(11):3554-3563. PubMed ID: 30137686
[TBL] [Abstract][Full Text] [Related]
3. [A successful resected case of advanced esophageal cancer with early gastric cancer responding to neoadjuvant chemotherapy of docetaxel, CDDP and 5-FU].
Matsutani T; Yoshida H; Sasajima K; Maruyama H; Yokoyama T; Matsushita A; Hirakata A; Takao Y; Umakoshi M; Hayakawa T; Katayama H; Hosone M; Uchida E
Gan To Kagaku Ryoho; 2012 Apr; 39(4):645-8. PubMed ID: 22504694
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.
Tanaka Y; Yoshida K; Tanahashi T; Okumura N; Matsuhashi N; Yamaguchi K
Cancer Sci; 2016 Jun; 107(6):764-72. PubMed ID: 27061001
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study.
Fujita Y; Hiramatsu M; Kawai M; Sumiyoshi K; Nishimura H; Tanigawa N
Dis Esophagus; 2008; 21(6):496-501. PubMed ID: 18840134
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant Triplet Combination Chemotherapy(UDON Therapy)in Esophageal Cancer Patients with Impaired Renal Function-A Retrospective Study].
Kimura Y; Shiraishi O; Iwama M; Kato H; Kawakami H; Okuno T; Hiraki Y; Yasuda A; Shinkai M; Imano M; Nakagawa K; Yasuda T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2173-2175. PubMed ID: 32156869
[TBL] [Abstract][Full Text] [Related]
7. [Long-Term Complete Response in Postoperative Multiple Lung and Mediastinal Lymph Node Metastases of Esophageal Cancer Using Systemic Chemotherapy with DCF Treatment - A Case Report].
Katsumi C; Bamba T; Nakagawa S; Aizawa M; Matsuki A; Yabusaki H; Homma K
Gan To Kagaku Ryoho; 2017 Jan; 44(1):75-78. PubMed ID: 28174385
[TBL] [Abstract][Full Text] [Related]
8. Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
Kajiura S; Hosokawa A; Yoshita H; Ueda Y; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
Am J Clin Oncol; 2016 Feb; 39(1):13-7. PubMed ID: 24322336
[TBL] [Abstract][Full Text] [Related]
9. [Pathological Complete Response in a Case of Advanced Esophageal Cancer with Widespread Lymph Node Metastases Treated Using Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-FU(DCF therapy)].
Noro H; Hirao T; Takaichi S; Son C; Iwamoto K; Kono E; Yasumasa K; Mizuno H; Morimoto Y; Hatanaka N; Yamasaki Y
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2178-2180. PubMed ID: 28133261
[TBL] [Abstract][Full Text] [Related]
10. [Safety and Efficacy of Neoadjuvant Chemotherapy(UDON: 5-FU, Docetaxel, and Nedaplatin)for Esophageal Cancer].
Konishi T; Komatsu S; Takeda R; Kanazawa H; Soga K; Shimomura K; Ikeda J; Taniguchi F; Shioaki Y
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1381-1383. PubMed ID: 38303281
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Advantage of Docetaxel/Cisplatin/ 5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence.
Yamashita K; Hosoda K; Moriya H; Katada C; Sugawara M; Mieno H; Komori S; Katada N; Watanabe M
Oncology; 2017; 92(4):221-228. PubMed ID: 28110330
[TBL] [Abstract][Full Text] [Related]
12. [A case of far advanced-esophageal squamous cell carcinoma successfully treated with docetaxel].
Takeshita N; Akutsu Y; Shuto K; Shiratori T; Kono T; Uesato M; Hoshino I; Miyazawa Y; Matsubara H
Gan To Kagaku Ryoho; 2013 Feb; 40(2):233-5. PubMed ID: 23411962
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation.
Yoshioka T; Sakayori M; Kato S; Chiba N; Miyazaki S; Nemoto K; Shibata H; Shimodaira H; Ohtsuka K; Kakudo Y; Sakata Y; Ishioka C
Int J Clin Oncol; 2006 Dec; 11(6):454-60. PubMed ID: 17180514
[TBL] [Abstract][Full Text] [Related]
14. A case of esophageal cancer with multiple lymph node metastases which responded to neoadjuvant chemotherapy (DCF therapy).
Shimakawa T; Naritaka Y; Asaka S; Isohata N; Yamaguchi K; Murayama M; Konno S; Katsube T; Ogawa K; Ide H
Anticancer Res; 2010 Jan; 30(1):221-6. PubMed ID: 20150639
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Advanced Esophageal Cancer Successfully Treated with DCF Chemotherapy Followed by Conversion Surgery].
Okada K; Takeoka T; Miki H; Kobayashi K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1623-1625. PubMed ID: 29394722
[TBL] [Abstract][Full Text] [Related]
16. A pilot trial of docetaxel and nedaplatin in cisplatin-pretreated relapsed or refractory esophageal squamous cell cancer.
Nakajima Y; Suzuki T; Haruki S; Ogiya K; Kawada K; Nishikage T; Nagai K; Kawano T
Hepatogastroenterology; 2008; 55(86-87):1631-5. PubMed ID: 19102357
[TBL] [Abstract][Full Text] [Related]
17. [A case of local advanced cervical esophageal cancer treated with concurrent radiochemotherapy followed by surgery].
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Takakita S; Kusumi F; Kato Y; Takeda H
Gan To Kagaku Ryoho; 1997 Oct; 24(13):2001-4. PubMed ID: 9350249
[TBL] [Abstract][Full Text] [Related]
18. [A case of primary esophageal carcinoma treated with 5-fluorouracil plus cisplatin and curatively resected after complete response].
Iwasaki K; Ogata T; Fujikawa H; Shirai J; Cho H; Yoshikawa T; Ohta Y; Tachibana S; Oosaka Y; Tsuchida A
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2146-8. PubMed ID: 24394041
[TBL] [Abstract][Full Text] [Related]
19. Phase II Trial of 5-Fluorouracil, Docetaxel, and Nedaplatin (UDON) Combination Therapy for Recurrent or Metastatic Esophageal Cancer.
Ueda H; Kawakami H; Nonagase Y; Takegawa N; Okuno T; Takahama T; Takeda M; Chiba Y; Tamura T; Nakagawa K
Oncologist; 2019 Feb; 24(2):163-e76. PubMed ID: 30361422
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis.
Akiyama Y; Sasaki A; Endo F; Nikai H; Amano S; Umemura A; Baba S; Chiba T; Kimura T; Takahara T; Nitta H; Otsuka K; Mizuno M; Kimura Y; Koeda K; Iwaya T
World J Surg Oncol; 2018 Jul; 16(1):122. PubMed ID: 29966526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
